Medscape Medical News
- Alert FDA Approves Tazemetostat (Tazvenik) for Rare Sarcoma
- FDA Approves Micra AV, Offers Leadless AV Synchronous Pacing
- Alert FDA Approves First Treatment for Thyroid Eye Disease
- Alert FDA Approves CVD Benefit for Once-Weekly Semaglutide
- Alert FDA Clears First Nasal Spray for Cluster Seizures in Kids 6+
- Alert FDA Expands Use of Antifungal Micafungin (Mycamine) to Newborns
- Alert FDA Approves Avapritinib (Ayvakit) for GIST with Mutation
- Alert FDA Approves Pembrolizumab for High-Risk Bladder Cancer
- Alert FDA OKs Faster Aspart Insulin for Children With Diabetes
- Alert New Option in Pancreatic Cancer: Olaparib for BRCA Mutations
- Alert FDA OKs Ophthalmic Stain for Vitreoretinal Surgery
- Alert FDA Okays First Generics for Eliquis (Apixaban)
- Alert FDA OKs Ubrogepant (Ubrelvy) for Acute Migraine Treatment
- FDA Approves Lemborexant (Dayvigo) for Insomnia
- Alert FDA OKs Lumateperone (Caplyta), First-in-Class for Schizophrenia
- Alert FDA OKs New Antibody Drug Conjugate for HER2+ Breast Cancer
- Alert FDA OKs First Vaccine Against Deadly Ebola Virus
- Alert FDA OKs First Tazarotene Lotion (Arazlo) for Acne Vulgaris
- Alert FDA Approves Novel Drug Enfortumab Vedotin for Urothelial Cancer
- Alert FDA OKs New Cysteine Hydrochloride Product Nouress